Effect of hydroxyurea on the transfusion requirements in patients with severe HbE-β-thalassaemia: A genotypic and phenotypic study

Journal of Clinical Pathology

Volumn 63, Issue 2, 2010, Pages 147-150

  Italia, Khushnooma Y ^a   Jijina, Farah F ^a   Merchant, Rashid ^b   Panjwani, Sangeeta ^b   Nadkarni, Anita H ^a   Sawant, Pratibha M ^a   Nair, Sona B ^a   Ghosh, Kanjaksha ^a   Colah, Roshan B ^a  

^a KEM HOSPITAL   (India)

^b DR BALABHAI NANAVATI HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GLOBIN; FERRITIN; GLOBIN; HEMOGLOBIN E; HEMOGLOBIN F; HYDROXYUREA;

ADOLESCENT; ADULT; ARTICLE; BETA THALASSEMIA; BLOOD TRANSFUSION; CHILD; CLINICAL ARTICLE; DISEASE SEVERITY; DNA POLYMORPHISM; FERRITIN BLOOD LEVEL; GENE DELETION; GENOTYPE; HUMAN; MEAN CORPUSCULAR VOLUME; PHENOTYPE; PRIORITY JOURNAL; SCHOOL CHILD;

ADOLESCENT; ADULT; BETA-GLOBINS; BETA-THALASSEMIA; BLOOD TRANSFUSION; CHILD; COMBINED MODALITY THERAPY; DEOXYRIBONUCLEASES, TYPE II SITE-SPECIFIC; FERRITINS; GENOTYPE; HEMOGLOBIN E; HUMANS; HYDROXYUREA; MUTATION; POLYMORPHISM, GENETIC; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77349108853     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jcp.2009.070391     Document Type: Article

References (24)

1. Weatherall DJ, Clegg JB (eds). Distribution and population genetics of the thalassemias. In: The thalassemia syndromes. 4th edn. Blackwell Scientific Publications, Oxford University Press, 2001;241-46.
2. Mohanty D, Colah R, Gorakshakar AC (eds). Jai Vigyan S and T Mission Project on community control of thalassemia syndromes-awareness, screening, genetic counseling and prevention. New Delhi: Indian Council of Medical Research, 2008:72-92.
3. E-globin gene. Nature 1982;300:768-9.
4. Fucharoen S, Winichagoon P, Pootrakul P, et al. Variable severity of Southeast Asian β-thalassemia/Hb E disease. Birth Defects 1987;23:241-8.
5. Premawardhena A, Fisher CA, Olivieri NF, et al. Hemoglobin E β thalassaemia in Sri Lanka. Lancet 2005;366:1467-70.
6. Loukopoulos D, Voskaridou E, Stamoulakatou A, et al. Hydroxyurea therapy in thalassaemia. Ann N Y Acad Sci 1998;850:120-8.
7. Alebouyeh M, Moussavi F, Haddad-Deylami H, et al. Hydroxyurea in the treatment of major β-thalassemia and importance of genetic screening. Ann Hematol 2004;83:430-3.
8. Italia K, Jain D, Gattani S, et al. Hydroxyurea in sickle cell disease - A study of clinico-pharmacological efficacy in the Indian haplotype. Blood Cells Mol Dis 2009;42:25-31.
9. Italia K, Jijina F, Merchant R, et al. Response to hydroxyurea in β thalassemia major and intermedia: experience in Western India. Clin Chim Acta 2009;407:10-15.
10. 0-thalassemia: consideration for treatment. Ann N Y Acad Sci 2005;1054:250-6.
11. Colah RB, Gorakshakar AC, Lu CY, et al. Application of covalent reverse dot blot hybridization for rapid prenatal diagnosis of the common Indian thalassemia syndromes. Indian Journal of Hematology and Blood Transfusion 1997;15:10-13.
12. Varawalla NY, Fitches AC, Old JM. Analysis of β-globin gene haplotypes in Asian Indians: origin and spread of β-thalassaemia on the Indian subcontinent. Hum Genet 1992;90:443-9.
13. Sutton M, Bouhassira EE, Nagel RL. Polymerase chain reaction amplification applied to the determination of β-like globin gene cluster haplotypes. Am J Hematol 1989;32:66-9.
14. Flint J, Harding RM, Boyce AJ, et al. The population genetics of the haemoglobinopathies. Baillieres Clin Haematol 1993;6:215-62.
15. Tan AS, Quah TC, Low PS, et al. A rapid and reliable 7-deletion multiplex polymerase chain reaction assay for α-thalassemia. Blood 2001;98:250-1.
16. De M, Halder A, Podder S, et al. Anemia and hemoglobinopathies in tribal population of Eastern and North-eastern India. Hematology 2006;11:371-3.
17. Cunningham MJ, Sankaran VG, Nathan DG, et al. The thalassemias. In: Orkin SH, Nathan DG, Ginsburg D, et al, eds. Hematology of infancy and childhood 7th edn. Philadelphia: Saunders Elsevier Publication, 2009;1015-06.
18. Nadkarni A, Ghosh K, Gorakshakar AC, et al. Variable clinical severity of HbE-β thalassemia among Indians. J Assoc Physicians India 1999;47:966-8.
19. Agarwal S, Gulati R, Singh K. Hemoglobin E-β thalassemia in Uttar Pradesh. Indian Pediatr 1997;34:287-92.
20. Agarwal MB. The burden of haemoglobinopathies in India- Time to wake up? J Assoc Physicians India 2005;53:1017-18.
21. Fucharoen S, Siritanaratkul N, Winichagoon P, et al. Hydroxyurea increases hemoglobin F levels and improves the effectiveness of erythropoiesis in β- thalassemia/hemoglobin E disease. Blood 1996;87:887-92.
22. Hoppe C, Vichinsky E, Lewis B, et al. Hydroxyurea and sodium phenylbutyrate therapy in thalassemia intermedia. Am J Hematol 1999;62:221-7.
23. Yavarian M, Karimi M, Bakker E, et al. Response to hydroxyurea treatment in Iranian transfusion-dependent β-thalassemia patients. Haematologica 2004;89:1172-8.
24. Fucharoen S. Hemoglobin E disorder. In: Steinberg MH, Forget BG, Higgs DR, et al, eds. Disorders of hemoglobin - genetics, pathophysiology and clinical management Cambridge: Cambridge University Press. 2001:1139-51.